A evolution of the antibody, initially known as MORAb-004, illustrates a important undertaking in cancer treatment. The team at its developers started research on this humanized monoclonal antibody targeting CD3, https://shaunahwyr624155.activoblog.com/51514782/ontuxizumab-morab-004-a-deep-dive-into-its-development